Atos receives offer from French state

The French government has made an offer to buy parts of Atos SE it considers to be strategic for an enterprise value of €500 ...
Atossa Therapeutics has strong financials with $79.5 million in cash and a cash runway of 13-14 quarters, minimizing ...
Atos has a 12-month low of $0.37 and a 12-month high of $8.53. The stock’s 50-day moving average price is $0.89 and its two ...
Highlights Anti-Cancer Activity of (Z)-Endoxifen-Related Compounds in ERα+ Breast CancerSEATTLE, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Atossa Therapeutics (NASDAQ:ATOS – Get Free Report) was downgraded by StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Monday. Several other research firms have ...
Atossa Therapeutics (ATOS) announced that five abstracts featuring data on (Z)-endoxifen have been accepted for presentation at the San Antonio ...
Since its time as a high-altitude training site for Olympic athletes in 1968, South Lake Tahoe has attracted those who ...